The #WCGIC2023 exhibit hall was full of excitement today. Connections were being made between new and old delegates exploring the latest developments in the field.

#oncology #oncology research #cancer #CancerResearch #barcelona

Dr. José Pérez, MEDSIR Medical Associate and Deputy Director at the International Breast Cancer Center, and a key figure in the #PHERGain trial, underscores the importance of its publication in The Lancet, a leading global academic journal.
#BreastCancer #OncologyResearch

Don’t miss MBN2023!
Registration: bit.ly/MBN2023Registr…
Updated Programme:
bit.ly/MBN2023Program…

Don't forget! We’ll wait for you.

#MBN2023 #NeverStopLearning #NSLTV #GretaOncoplastic #Oncology #Oncology Research

Dr. Javier Cortes MD PhD presented the #PHERGain 3-year disease-free survival results at #ASCO23 and, following The Lancet publication, emphasized the achievements attained in this study.

Learn more about the study: medsir.org/post/revolutio…

#MEDSIRtheLancet #OncologyResearch

Now it’s time for Gastrointestinal cancer at the 50th anniversary of the medical oncology service Hospital 12 Octubre. Great panels and Top speakers🧬🔬 #oncologyresearch #h120 #oncologiamedica

Wrapping up the #CRNHDRs23 Symposium with Networking Session at Level 4 Foyer, Susan Wakil Health Building 🍴🥂 #PhD andECRnetwork #OncologyResearch #PhD #ECR #Engagingnetworking #CancerResearcher

Congratulations Dr. Zaibunnisa Zaibunnisa for winning the #FrancescaMartiniPrize at #SIBBM23 for her poster on 'IGFL1: a new factor in prostate cancer with immune activity.' 👏🏆 #OncologyResearch SIBBM

🚨 Heads up! The deadline for applications to the VHIO & Fundación BBVA Symposium is October 7th. Don't miss out! Register and get more details here: linke.to/VHIO_BBVA_F_I_… ⏳ 

#OncologyResearch #CellBasedTherapiesVHIOBBVA

Protocol training today! #oncologyresearch #teamscience

Treatment is selected judiciously and personalized to how it affects a man’s life. SCHEDULE AN APPOINTMENT 310-827-7707.

#prostatecancer #fïghtcancer #losangeles #oncology #oncologist #oncology research #medicaladvancements #oncology research #menshealth #menshealth month

We examined survival outcomes for Stage IV gastric cancer patients with Krukenberg tumors - Zouina Sarfraz
Anwaar Saeed
oncodaily.com/66885.html

#Cancer #Chemotherapy #OncoDaily #Oncology #GastrointestinalCancer #KrukenbergTumors #Oncology Research

Lambda & Novum are exhibiting at #ASCO2024 . To schedule a meeting,📧[email protected] & explore how we can support your Oncology & Hematology #DrugDevelopment projects.
#ClinicalTrials #ClinicalDevelopment #CancerResearch #OncologyClinicalTrials #OncologyResearch #GlobalCRO

Left my mark on Boston! 4 national presentations in 3 days! Love my tribe! Onco rock stars! #APTACSM2024 #oncologyresearch

As we are close to ASCO 2024, don't miss this opportunity to prepare yourself for ASCO 2024. Tune in to the LARVOL ONCOLOGY DATA WEBINAR for an engaging session.

Add to your calendar now! lnkd.in/gKsibQCQ

#ASCO24 #LARVOL #LARVOL CLIN #Oncology #Oncology Research

#ESMOBreast24 : What do you find the most relevant #ScientificAdvancements in #OncologyResearch ? Share the newest findings that you consider having the potential to improve #CancerCare in #bcsm . #BreastCancer #ESMOAmbassadors

🔹 New Study Alert: Investigating KRAS targeting in #cancer , a field once deemed undruggable. Recent breakthroughs, like allele-specific targeting, show promise in non-small cell lung & pancreatic cancer. Blueprint for future KRAS therapeutics outlined.

#OncologyResearch #KRAS

Poster presentation! World Congress on Gastrointestinal Cancer
Latin american women with gastric adenocarcinoma and ovarian metastasis: therapeutic approaches and survival #WCGIC2023 #Oncology #Oncology Research #GastricCancer Instituto Nacional de Cancerología

First day at II Annual Meeting of Conexión Cáncer CSIC. #science #basicresearch #cancer #oncologyresearch

🔹The ASCENT trial explores combining afatinib with chemoradiation, with or without surgery, in stage III EGFR-mutant NSCLC.
Results show a 63% response rate to induction TKI, with promising PFS (2.6 years) and OS (5.8 years).

#LungCancer #NSCLC #OncologyResearch Allison Chang

Oooh, super excited to be a ESMO - Eur. Oncology #ESMO23 Social Media Ambassador with this amazing group of #oncologyresearch all⭐️⭐️⭐️
📲 look forward to share my take on late-breaking updates from Madrid
👇resharing my recommended key #abstracts in #GIOncology
Stay tuned 👋
OncoAlert